The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
SOHO 2023 | The need to improve prognostic tools and implement targeted therapies in follicular lymphoma
Tycel Phillips, MD, City of Hope, Duarte, CA, provides an overview of the prognostic tools used for patients with follicular lymphoma (FL) and highlights the need to refine these tools to identify patients with high-risk disease. Dr Phillips also talks on treatment approaches available for patients with FL and addresses the lack of therapies targeted towards specific mutations in this disease. This interview took place at the Eleventh Annual Meeting of the Society of Hematologic Oncology (SOHO 2023) held in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
